Can long-term results following balloon angioplasty be the "crystal ball" to predict outcome following bioresorbable vascular scaffolds?

about

Current and future perspectives on drug-eluting bioresorbable coronary scaffolds.

P2860

Q38224405-5D79E6D6-C548-487D-815D-42551E0F0FF4

P2860

Can long-term results following balloon angioplasty be the "crystal ball" to predict outcome following bioresorbable vascular scaffolds?

Item

http://www.wikidata.org/entity/Q42634423

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Can long-term results followin ...... resorbable vascular scaffolds?

@en

Can long-term results followin ...... resorbable vascular scaffolds?

@nl

type

Item

label

Can long-term results followin ...... resorbable vascular scaffolds?

@en

Can long-term results followin ...... resorbable vascular scaffolds?

@nl

prefLabel

Can long-term results followin ...... resorbable vascular scaffolds?

@en

Can long-term results followin ...... resorbable vascular scaffolds?

@nl

P1476

Can long-term results followin ...... resorbable vascular scaffolds?

@en

P2093

Antonio Colombo

http://www.w3.org/2001/XMLSchema#string

P2860

Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization

Assimilating the current clinical data of fully bioabsorbable stents.

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial.

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents

Very long-term (15 to 23 years) outcomes of successful balloon angioplasty compared with bare metal coronary stenting

Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.

Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronar

A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study.

Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes.

P304

e005272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1161/JAHA.112.005272

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Azeem Latib

P577

2012-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23316307

http://www.w3.org/2001/XMLSchema#string

P932

3541609

http://www.w3.org/2001/XMLSchema#string

Can long-term results following balloon angioplasty be the "crystal ball" to predict outcome following bioresorbable vascular scaffolds?

about

P2860

P2860

Can long-term results following balloon angioplasty be the "crystal ball" to predict outcome following bioresorbable vascular scaffolds?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932